Virgilio Eleonora, Vecchio Domizia, Sarnelli Maria Francesca, Solara Valentina, Cantello Roberto, Comi Cristoforo
Neurology Unit, Maggiore Della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Neurology Unit, S. Andrea Hospital, Department of Translational Medicine, University of Piemonte Orientale, 13100 Vercelli, Italy.
J Clin Med. 2023 Jan 15;12(2):685. doi: 10.3390/jcm12020685.
We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived cognitive decline and long disease duration to investigate early predictors of future cognitive impairment (CI) and motor disability. Sixty-five patients complaining of cognitive decline were assessed with an extensive neuropsychological battery at the last clinical follow-up and classified as mildly impaired, severely impaired, and cognitively spared based on the results. Motor disability was assessed with EDSS, MSSS, and ARMSS. Baseline demographic, clinical, and imaging parameters were retrospectively collected and inserted in separate multivariate regression models to investigate the predictive power of future impairment. Twenty-one patients (32.3%) showed no CI, seventeen (26.2%) showed mild CI, and twenty-seven (41.5%) showed severe CI. Older and less educated patients with higher EDSS, longer disease duration, and higher white matter lesion load (WMLL) at diagnosis (particularly with cerebellar involvement) were more likely to develop CI after a mean follow-up from diagnosis of 16.5 ± 6.9 years. DMT exposure was protective. The multivariate regression analyses confirmed WMLL, disease duration, and educational levels as the parameters with significant predictive value for future CI (R2 adjusted: 0.338 : 0.001). Older patients with progressive phenotype both at diagnosis and T1 were more likely to be not fully ambulatory at T1 (R2 adjusted: 0.796 : 0.0001). Our results further expand knowledge on early predictors of cognitive decline and evolution over time.
我们对患有认知功能减退且病程较长的多发性硬化症(MS)患者进行了回顾性分析,以探究未来认知障碍(CI)和运动功能障碍的早期预测因素。在最后一次临床随访时,对65名主诉认知功能减退的患者进行了全面的神经心理测试,并根据测试结果将其分为轻度受损、重度受损和认知功能未受损三类。使用扩展残疾状态量表(EDSS)、多发性硬化症功能综合评分(MSSS)和上肢运动评分量表(ARMSS)评估运动功能障碍。回顾性收集基线人口统计学、临床和影像学参数,并将其纳入单独的多变量回归模型,以研究未来功能障碍的预测能力。21名患者(32.3%)未出现认知障碍,17名患者(26.2%)出现轻度认知障碍,27名患者(41.5%)出现重度认知障碍。年龄较大、受教育程度较低、EDSS较高、病程较长以及诊断时白质病变负荷(WMLL)较高(尤其是小脑受累)的患者,在诊断后平均随访16.5±6.9年时更易出现认知障碍。使用疾病修正治疗(DMT)具有保护作用。多变量回归分析证实,WMLL、病程和教育水平是未来认知障碍的重要预测参数(调整后的R2:0.338,P=0.001)。诊断时和T1期具有进展性表型的老年患者在T1期更有可能无法完全独立行走(调整后的R2:0.796,P=0.0001)。我们的研究结果进一步拓展了对认知功能减退早期预测因素及随时间演变情况的认识。